The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants.

NPJ Genom Med 2018 9;3. Epub 2018 Feb 9.

Rady Children's Institute for Genomic Medicine, San Diego, CA 92123 USA.

Genetic disorders are a leading cause of morbidity and mortality in infants in neonatal and pediatric intensive care units (NICU/PICU). While genomic sequencing is useful for genetic disease diagnosis, results are usually reported too late to guide inpatient management. We performed an investigator-initiated, partially blinded, pragmatic, randomized, controlled trial to test the hypothesis that rapid whole-genome sequencing (rWGS) increased the proportion of NICU/PICU infants receiving a genetic diagnosis within 28 days. The participants were families with infants aged <4 months in a regional NICU and PICU, with illnesses of unknown etiology. The intervention was trio rWGS. Enrollment from October 2014 to June 2016, and follow-up until November 2016. Of all, 26 female infants, 37 male infants, and 2 infants of undetermined sex were randomized to receive rWGS plus standard genetic tests ( = 32, cases) or standard genetic tests alone ( = 33, controls). The study was terminated early due to loss of equipoise: 73% (24) controls received genomic sequencing as standard tests, and 15% (five) controls underwent compassionate cross-over to receive rWGS. Nevertheless, intention to treat analysis showed the rate of genetic diagnosis within 28 days of enrollment (the primary end-point) to be higher in cases (31%, 10 of 32) than controls (3%, 1 of 33; difference, 28% [95% CI, 10-46%];  = 0.003). Among infants enrolled in the first 25 days of life, the rate of neonatal diagnosis was higher in cases (32%, 7 of 22) than controls (0%, 0 of 23; difference, 32% [95% CI, 11-53%]; = 0.004). Median age at diagnosis (25 days [range 14-90] in cases vs. 130 days [range 37-451] in controls) and median time to diagnosis (13 days [range 1-84] in cases, vs. 107 days [range 21-429] in controls) were significantly less in cases than controls ( = 0.04). In conclusion, rWGS increased the proportion of NICU/PICU infants who received timely diagnoses of genetic diseases.

Download full-text PDF

Source Listing
February 2018
17 Reads

Publication Analysis

Top Keywords

rapid whole-genome
controlled trial
whole-genome sequencing
management performed
inpatient management
guide inpatient
performed investigator-initiated
investigator-initiated partially
blinded pragmatic
partially blinded
late guide
reported late
sequencing genetic
genomic sequencing
nicu/picu genomic
care units
disease diagnosis
diagnosis reported
pragmatic randomized
units nicu/picu


(Supplied by CrossRef)

ED Green et al.
Nature 2011

EA Worthey et al.
Genet. Med. 2011

MN Bainbridge et al.
Sci. Transl. Med. 2011

TJ Dixon-Salazar et al.
Sci. Transl. Med. 2012

S Soden et al.
Sci. Transl. Med. 2014

LK Willig et al.
Lancet Respir. Med. 2015

Z Stark et al.
Genet. Med. 2016

TA Manolio et al.
Sci. Transl. Med. 2015

FS Collins et al.
N. Engl. J. Med. 2015

KA Phillips et al.
Genet. Med. 2017

MC Roberts et al.
Genet. Med. 2017

Similar Publications